These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37439176)

  • 1. [Prediction of 1p/19q codeletion status in diffuse lower-grade glioma using multimodal MRI radiomics].
    Lu M; Qu Y; Ma A; Zhu J; Zou X; Lin G; Li Y; Liu X; Wen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):1023-1028. PubMed ID: 37439176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
    Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
    BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
    He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
    BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.
    Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN
    Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
    J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
    Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC; Lo CM; Wang SH; Su EC
    BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-parametric Z-spectral MRI may have a good performance for glioma stratification in clinical patients.
    Su C; Xu S; Lin D; He H; Chen Z; Damen FC; Ke C; Lv X; Cai K
    Eur Radiol; 2022 Jan; 32(1):101-111. PubMed ID: 34272981
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zaragori T; Oster J; Roch V; Hossu G; Chawki MB; Grignon R; Pouget C; Gauchotte G; Rech F; Blonski M; Taillandier L; Imbert L; Verger A
    J Nucl Med; 2022 Jan; 63(1):147-157. PubMed ID: 34016731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.
    Zhao K; Sun G; Wang Q; Xue Z; Liu G; Xia Y; Yao A; Zhao Y; You N; Yang C; Xu B
    Acad Radiol; 2021 Jul; 28(7):e189-e198. PubMed ID: 32359929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of
    Park YW; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Kang SG; Kim EH; Lee SK
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):693-698. PubMed ID: 29519794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
    Kocak B; Durmaz ES; Ates E; Sel I; Turgut Gunes S; Kaya OK; Zeynalova A; Kilickesmez O
    Eur Radiol; 2020 Feb; 30(2):877-886. PubMed ID: 31691122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
    Yang X; Lin Y; Xing Z; She D; Su Y; Cao D
    Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas.
    Kong Z; Jiang C; Zhang Y; Liu S; Liu D; Liu Z; Chen W; Liu P; Yang T; Lyu Y; Zhao D; You H; Wang Y; Ma W; Feng F
    Front Neurol; 2020; 11():551771. PubMed ID: 33192984
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion.
    Li Y; Ammari S; Lawrance L; Quillent A; Assi T; Lassau N; Chouzenoux E
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI radiomics analysis of molecular alterations in low-grade gliomas.
    Shofty B; Artzi M; Ben Bashat D; Liberman G; Haim O; Kashanian A; Bokstein F; Blumenthal DT; Ram Z; Shahar T
    Int J Comput Assist Radiol Surg; 2018 Apr; 13(4):563-571. PubMed ID: 29270916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Analysis of Quantitative Maps from Synthetic MRI for Predicting Grades and Molecular Subtypes of Diffuse Gliomas.
    Lin D; Liu J; Ke C; Chen H; Li J; Xie Y; Ma J; Lv X; Feng Y
    Clin Neuroradiol; 2024 Jun; ():. PubMed ID: 38858272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a non-invasive molecular status predictor of chromosome 1p/19q co-deletion based on MRI radiomics analysis of Low Grade Glioma patients.
    Casale R; Lavrova E; Sanduleanu S; Woodruff HC; Lambin P
    Eur J Radiol; 2021 Jun; 139():109678. PubMed ID: 33848780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.